Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-981 in erosive hand osteoarthritis
2014-001096-31Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Dec 2014
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of lutikizumab in erosive hand osteoarthritis (EHOA), sponsored by AbbVie Inc.. Started Dec 2014; status: completed.
02
Drugs
lutikizumab
03
Conditions
erosive hand osteoarthritis (EHOA)
Beyond the preview
Go deeper on 2014-001096-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001096-31.